Zanella E, Rulli F, Sianesi M, Sciacchitano S, Danese D, Pontecorvi A, Farinon A M
Department of Surgery, University of Rome Tor Vergata, Italy.
Ann Ital Chir. 2001 May-Jun;72(3):293-7.
The occurrence of thyroid malignancy is considered a rare event in hyperthyroid patients. With the aim of assessing the clinical relevance of this association, we have analyzed the incidence of thyroid cancer in hyperthyroid patients treated by surgery. The incidence of thyroid cancer was retrospectively evaluated in 202 hyperthyroid patients who underwent thyroidectomy during a twenty-year period. A thyroid cancer was diagnosed in 12 cases (5.9 per cent). Histologic examination revealed the presence of papillary carcinoma in 9 cases, follicular carcinoma in 1 case and Hürthle cell carcinoma in 2 cases. The association between thyroid cancer and hyperthyroidism was more frequent in toxic adenomas (17.8 per cent) than in toxic diffuse (5.3 per cent) or multinodular goiters (1.7 per cent). In 8 patients they presented as an occult carcinoma (maximum diameter below 1 cm), but unfavourable histologic features, such as local invasiveness and multifocality, were found in 5 of them. Follow-up data indicate that all 12 patients are currently alive and apparently free of disease. Hyperthyroid patients, particularly those affected by toxic adenomas, should be carefully evaluated to exclude the presence of concurrent malignancy. A special attention should be made moreover to the presence of "occult" lesions that, in our study was characterized in a higher proportion (62.5 per cent) of cases, by unfavourable histologic features.
甲状腺恶性肿瘤的发生在甲亢患者中被认为是罕见事件。为了评估这种关联的临床相关性,我们分析了接受手术治疗的甲亢患者中甲状腺癌的发生率。回顾性评估了202例在20年期间接受甲状腺切除术的甲亢患者的甲状腺癌发生率。12例(5.9%)被诊断为甲状腺癌。组织学检查显示,9例为乳头状癌,1例为滤泡状癌,2例为许特莱细胞癌。甲状腺癌与甲亢的关联在毒性腺瘤中(17.8%)比在毒性弥漫性甲状腺肿(5.3%)或多结节性甲状腺肿(1.7%)中更常见。在8例患者中,甲状腺癌表现为隐匿性癌(最大直径小于1厘米),但其中5例具有局部侵袭性和多灶性等不良组织学特征。随访数据表明,所有12例患者目前均存活且显然无疾病。甲亢患者,尤其是那些患有毒性腺瘤的患者,应仔细评估以排除并发恶性肿瘤的存在。此外,应特别关注“隐匿性”病变的存在,在我们的研究中,这类病变在较高比例(62.5%)的病例中具有不良组织学特征。